The global primary cells market size is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. Growth in the primary cells market is mainly driven by factors such as increasing cancer research, the advantages of primary human cells over cell lines, the increasing demand for monoclonal antibodies, rapid growth in the biotechnology & biopharmaceutical industries, and growing focus on personalized medicine. Biomedical research using primary cells in 3D cultures is also expected to provide a wide range of growth opportunities for players in the market. On the other hand, concerns regarding primary cell culture contamination are expected to limit market growth to a certain extent in the coming years.
Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960
The human primary cells segment accounted for the largest share of the primary cells market, by origin segment, in 2019
Based on origin, the primary cells market is segmented into human and animal primary cells. The human primary cells segment accounted for the largest share in the primary cells market in 2019. The growing application areas of human stem cells and the rising incidence of cancer are the major factors driving the growth of this segment.
Hepatocytes segment to register the highest growth rate during the forecast period
Based on type, the primary cells market is segmented into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. In 2019, the hepatocytes segment accounted for the highest growth rate. This can be attributed to the increasing incidence of liver cancer & pediatric liver diseases across the globe, increasing research funding by key pharma players, and the emergence of new companies dedicated to liver therapeutics research.
The life science research companies segment accounted for the largest share of the primary cells market, by end user segment, in 2019
Based on end-users, the primary cells market is segmented into life science research companies and research institutes. In 2019, the life science research companies segment for the largest share in the primary cells market. Increasing cancer research in life science research companies, the increasing number of R&D facilities, high adoption of primary cells in cell-based experiments, and the increasing investments of companies in cell-based research are the major factors driving the growth of this segment.
North America is the largest regional market for primary cells market
The primary cells market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the primary cells market. The growth in the North American primary cells market can be attributed to increasing funding for cancer research, growing life science research sector, expansion of the healthcare sector, and the high adoption of stem cell therapy & cell immunotherapies for the treatment of cancer and chronic diseases.
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (US), PPA Research Group, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sàrl (Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and Biopredic International (France).
Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960
Don’t miss out on business opportunities in Primary Cells Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441